<!doctype html>
<html>
<head>
	<meta charset="utf-8">
	<title>final-task</title>
	<link rel="stylesheet" href="stylesheets/style.CSS">
</head>
<body>
	<div class="wrapper">
		<nav>
			<button data-bind="click: turnOnSlide1">Graphics</button>
			<button data-bind="click: turnOnSlide2" class="button2">Calculator</button>
			<button>Competitors</button>
		</nav>
		<section class="" data-bind="visible: firstSlide">
			<h2>Xarelto<sup>®</sup>: An Effective Treatment Option<br/>in Your VTE Patients width Cancer<sup>a,8</sup></h2>
			<p class="signature">%PATIENTS<sup>b</sup></p>
			<div class="graphics" >
				<div class="graduation-wrapper">
					<ul class="graduation">
						<li>8 –</li>
						<li>7 –</li>
						<li>6 –</li>
						<li>5 –</li>
						<li>4 –</li>
						<li>3 –</li>
						<li>2 –</li>
						<li>1 –</li>
						<li>0</li>
					</ul>
				</div>
				<p class="graphics-data">HR 0.69;<br>95% CI 0.36-1.33</p>
				<div class="wrapgraph">
					<div class="firstBlock">
						<p class="graphic-data">7.1<p/>
						<p class="graphic-data">n=20/281</p>
						<p class="graphic-data">ENOHAPARIN /<br/> VKA</p>
					</div>
					<div class="secondBlock">
						<p class="graphic-data">5.1<p/>
						<p class="graphic-data">n=16/316</p>
						<p class="graphic-data">XARELTO</p>
					</div>
					<div class="horizontal-line">
						<hr>
						<p>0</p>
						<p>Cancer</p>
					</div>
				</div>
				<div class="minifotter">
					<p><sup>a</sup>Xarelto is contraindicated in lesions or conditions, if they are considered to be a significant risk for major 
					bleeding, which may include the presence of malignant neoplasms at high risk of bleeding.<br>
					<sup>b</sup>Outcome: symptomatic, recurrent VTE.</p>
				</div>
			</div>
		</section>
	</div>
	<script src="scripts/knockout-3.1.0.js"></script>
	<script src="scripts/script.js"></script>
</body>
</html>